Predictive oncology announces reverse stock split

Common stock will begin trading on split-adjusted basis on april 24, 2023 eagan, minn., april 20, 2023 (globe newswire) -- predictive oncology inc. (nasdaq: poai) (“predictive oncology” or the “company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares.
POAI Ratings Summary
POAI Quant Ranking